Start for free
Start for free
HI

Heidelberg Innovation

Europe, Baden-Wurttemberg, Germany, Heidelberg

Description

Heidelberg Innovation is a German investment company catering to life sciences companies with a focus on medical technology.

Investor Profile

Heidelberg Innovation has made 10 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series B (40%)
  • Series C (20%)
  • Series A (20%)
  • Series F (10%)
  • Series Unknown (10%)

Country Focus

  • Germany (60%)
  • Switzerland (20%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Health Diagnostics
  • Therapeutics
  • Medical Device
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Heidelberg Innovation frequently co-invest with?

Gimv
Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 1
HBM Healthcare Investments
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Novartis Venture Fund
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
CA
Carnegie Asset Management
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
3i Group
3i Group
Europe, England, United Kingdom, London
Co-Investments: 1
NGN Capital
NGN Capital
North America, New York, United States, New York
Co-Investments: 2
Dow
Dow
North America, Michigan, United States, Midland
Co-Investments: 1
MH
Mannheim Holdings
North America, New York, United States, Brooklyn
Co-Investments: 2
Oxford Bioscience Partners
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Bayern Kapital
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 2

What are some of recent deals done by Heidelberg Innovation?

Lophius Biosciences

Regensburg, Bayern, Germany

Lophius Biosciences is a biotechnology company developing products for the diagnosis of acute infectious and autoimmune diseases.

BiotechnologyHealth CareHealth Diagnostics
Series UnknownMay 8, 2014
Amount Raised: $2,768,331
Vasopharm

Würzburg, Bayern, Germany

Vasopharm is focused on the R&D of novel therapeutics for the treatment of cerebro and cardiovascular diseases and their symptoms.

BiotechnologyMedicalTherapeutics
Series FJun 24, 2013
Amount Raised: $6,500,000
MTM Laboratories

Heidelberg, Baden-Wurttemberg, Germany

MTM Laboratories manufactures in-vitro diagnostics for the early-detection and diagnosis of cervical and other cancers.

BiotechnologyHealth DiagnosticsMedical
Series COct 10, 2006
Amount Raised: $28,000,000
Vasopharm

Würzburg, Bayern, Germany

Vasopharm is focused on the R&D of novel therapeutics for the treatment of cerebro and cardiovascular diseases and their symptoms.

BiotechnologyMedicalTherapeutics
Series BJan 30, 2006
Amount Raised: $11,800,000
Santhera Pharmaceuticals

Liestal, Basel-Landschaft, Switzerland

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

BiotechnologyHealth CarePharmaceutical
Series BDec 20, 2005
Amount Raised: $18,997,524
Alantos Pharmaceuticals

Cambridge, Massachusetts, United States

Alantos Pharmaceuticals is a dynamic international biopharmaceutical company focused on developing small molecule pharmaceuticals.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BMar 10, 2005
Amount Raised: $20,000,000
Santhera Pharmaceuticals

Liestal, Basel-Landschaft, Switzerland

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

BiotechnologyHealth CarePharmaceutical
Series ADec 17, 2004
Amount Raised: $18,600,696
Pelikan Technologies

Palo Alto, California, United States

Pelikan Technologies develops hand-held diagnostic and monitoring devices.

BiotechnologyHealth CareMedical Device
Series CDec 16, 2002
Amount Raised: $14,000,000
CellZome

Heidelberg, Baden-Wurttemberg, Germany

CellZome is a pharmaceutical company that discovers, develops, and commercializes kinase-targeted drugs.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BMar 1, 2001
Amount Raised: $31,000,000
MTM Laboratories

Heidelberg, Baden-Wurttemberg, Germany

MTM Laboratories manufactures in-vitro diagnostics for the early-detection and diagnosis of cervical and other cancers.

BiotechnologyHealth DiagnosticsMedical
Series AAug 30, 1999
Amount Raised: $1,672,757
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator